Distinct Roles of Surface Nanostructure and Polymer Degradation in Fibroblast Response to Device Design

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Cell Biology

Background:

• Fibrotic encapsulation is a primary cause of biomedical device failure.
• Fibroblasts, not just the immune system, are key regulators of foreign body response.
• Understanding fibroblast activation is crucial for improving device longevity.

Purpose of the Study:

• To investigate how porous device design influences fibroblast activation into myofibroblasts.
• To assess the impact of nanoparticles and polymer matrix on myofibroblast differentiation.
• To elucidate mechanisms by which device design affects cellular response and fibrosis.

Main Methods:

• Primary human dermal fibroblasts cultured with devices for four weeks.
• Evaluation of myofibroblast markers (αSMA, vinculin, integrins) under varying conditions.
• Analysis of tantalum oxide nanoparticles (0-20wt%) and polymer matrices (PLGA vs. PCL).

Main Results:

• Tantalum oxide nanoparticles showed minimal effect, down-regulating αSMA expression.
• Fast-degrading PLGA significantly upregulated multiple myofibroblast markers compared to PCL.
• Lactic acid release from PLGA degradation was identified as a key factor affecting cellular metabolism.

Conclusions:

• Device design, particularly the polymer matrix and its degradation products, significantly impacts fibroblast activation.
• PLGA's degradation products, like lactic acid, promote fibrotic responses.
• Optimizing device design is critical to mitigate fibrosis and enhance biomedical device success.